The more distributed regions of frontal hypometabolism would also be expected in ALS patients meeting criteria of comorbid frontotemporal lobar degeneration (FTLD), with a well-characterized clinical association between FTLD and ALS likely reflecting the underlying molecular pathophysiology of these conditions related to TDP-43 proteinopathy. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.